Role of different anti-seizure medications on carotid intima-media thickness: A systematic review and meta-analysis
Afshan Davari1,2, Amir Reza Bahadori1, Ali Mohammadi-Asl1
1Iranian Center of Neurological Research, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.
Background:
Various types of anti-seizure medication (ASMs) may have an impact on the cardiac health of patients who have epilepsy. One of the most important noninvasive predictive factors related to cardiovascular disease is carotid intima-media thickness (CIMT). The objective of this systematic review and meta-analysis is to determine the effect of both mono- and poly-therapy with ASMs on CIMT.
Methods:
Four databases (PubMed, Scopus, Web of Science, and Embase) were searched for records. Studies that measured the effect of ASMs on CIMT were eligible to be included. The case and control data of studies were extracted. Also, the quality assessment of each included study was assessed by the risk of bias in non-randomized studies of interventions (ROBINS-I) checklist. Additionally, the random-effect model analysis was performed by the Comprehensive Meta-Analysis Software (CMA) version 3.0.
Results:
Twenty-nine studies were included in the systematic review, and 15 studies were eligible to perform meta-analysis. Among both poly-therapy, and monotherapy with valproate sodium, carbamazepine, levetiracetam, and phenytoin, CIMT had significantly higher thickness compared to the control group (SMD: 1.82, 1.18, 1.33, 1.83, and 1.15 with 95%CI: [0.34, 3.3], [0.67, 1.7], [0.38, 2.27], [0.1, 3.56], and [-0.49, 2.8], respectively) (P-value: .001, .001, .001, .001, and .007, respectively).
Conclusion:
The potential risk of cardiovascular diseases related to CIMT may be elevated by using both mono- and polytherapy with valproate sodium, carbamazepine, levetiracetam, and phenytoin.
Related Concept Videos
01:26Atherosclerosis III: Management
01:17Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
01:08Antiepileptic Drugs: Sodium Channel Blockers
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
01:24Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...